BRIEF-Oncolytics U.S.-listed shares up 15.5 percent premarket

Thu Nov 21, 2013 7:53am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

NEW YORK Nov 21 (Reuters) - Oncolytics Biotech Inc : * U.S.-listed shares up 15.5 percent to $2.91 in premarket after data from head and neck cancer drug trial